about
Genomic diversity in myeloproliferative neoplasms: focus on myelofibrosisA phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis.The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Myelofibrosis 2012: it's complicated.
@en
type
label
Myelofibrosis 2012: it's complicated.
@en
prefLabel
Myelofibrosis 2012: it's complicated.
@en
P2093
P2860
P356
P1476
Myelofibrosis 2012: it's complicated.
@en
P2093
Dale M Frank
Elizabeth O Hexner
Harper G Hubbeling
P2860
P304
P356
10.1177/2040620712437754
P577
2012-06-01T00:00:00Z